Market Cap 101.91B
Revenue (ttm) 11.02B
Net Income (ttm) -535.60M
EPS (ttm) N/A
PE Ratio 26.06
Forward PE 24.82
Profit Margin -4.86%
Debt to Equity Ratio 0.00
Volume 1,404,000
Avg Vol 1,718,700
Day's Range N/A - N/A
Shares Out 256.39M
Stochastic %K 70%
Beta 0.44
Analysts Sell
Price Target $495.31

Company Profile

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 341 6100
Address:
50 Northern Avenue, Boston, United States
BosFreedom
BosFreedom Aug. 22 at 11:10 AM
$VRTX let’s get over 400 today. Please!!!🙏
0 · Reply
ChartHustla
ChartHustla Aug. 22 at 3:01 AM
$VRTX Vertex Pharmaceuticals dominates the cystic fibrosis market with a durable revenue stream pipeline beyond CF is the key to future growth
0 · Reply
pflory23
pflory23 Aug. 21 at 5:32 PM
$VRTX looking for any pullback to load more
0 · Reply
JoeB07
JoeB07 Aug. 21 at 3:28 PM
$INSM Why do the big holders continue to add shares at these prices!? Yes, Will Lewis is 3/3 on late stage drug trials. Yes, Brinsi is being compared to Humira, one of the biggest selling drugs in history. But the main reason they keep adding—Will Lewis is a business man. He’s indicated on CCs that he is not going to squander the revenue on a large numbers of frivolous research projects—think $VRTX. He’s going to start printing money for investors. And the big holders know this. And that’s why they continue to add at these crazy prices. Will Lewis isn’t only just focused on revenues, he’s going after profits too.
1 · Reply
Jmillie
Jmillie Aug. 21 at 3:41 AM
$VKTX think about how heavy shorts are right now. $VRTX potentially turned down $50 just last year. they could get acquired for $125 tomorrow. who knows. itll squeeze to $600 before they close the deal 😂😂 https://seekingalpha.com/news/4060945-viking-therapeutics-gains-amid-takeover-speculation
0 · Reply
JoeB07
JoeB07 Aug. 20 at 3:57 PM
$INSM $PLTR $VRTX $ALAB have fun! Get rich! Who wants to be an INSM millionaire with me!?
0 · Reply
Monkey_Banana_Genius
Monkey_Banana_Genius Aug. 20 at 2:24 PM
$VRTX trimmed some
2 · Reply
Monkey_Banana_Genius
Monkey_Banana_Genius Aug. 20 at 1:57 PM
$VRTX 💪
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 20 at 1:44 PM
$VRTX nice early pop
1 · Reply
falcon_trader11
falcon_trader11 Aug. 20 at 1:58 AM
$RNXT dipped after Q2 earnings due to a $2.9M loss, but don't miss the big wins! RenovoCath sales hit $422K, beating estimates by 28%. Now in 13 top cancer centers, up from 5, with repeat orders. Phase III trial got a green light, targeting a $1B+ market by early 2026. With $12.3M cash, a new sales pro, and TAMP cutting chemo side effects 65%, analysts see $4-$11.50 targets. PanTheR study starts by Sep end, plus ASTRO Sep 27-Oct 1 & AIMsymposium Nov 17. Missed $LLY at $705, $VRTX at $390, or $REGN at $572? $RNXT could be your next oncology star! $RNXT $LLY $VRTX $REGN
1 · Reply
Latest News on VRTX
Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet

Aug 12, 2025, 2:34 PM EDT - 10 days ago

Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet


Weakness In Vertex Stock Seen As Buying Opportunity

Aug 5, 2025, 2:05 PM EDT - 17 days ago

Weakness In Vertex Stock Seen As Buying Opportunity


Vertex Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 4:01 PM EDT - 18 days ago

Vertex Reports Second Quarter 2025 Financial Results


How Will VRTX Stock React To Its Upcoming Earnings?

Aug 2, 2025, 12:20 AM EDT - 20 days ago

How Will VRTX Stock React To Its Upcoming Earnings?


Vertex to Participate in Upcoming Investor Conferences

May 15, 2025, 4:05 PM EDT - 3 months ago

Vertex to Participate in Upcoming Investor Conferences


Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?

May 6, 2025, 4:28 PM EDT - 3 months ago

Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?


Vertex Reports First Quarter 2025 Financial Results

May 5, 2025, 4:01 PM EDT - 3 months ago

Vertex Reports First Quarter 2025 Financial Results


BosFreedom
BosFreedom Aug. 22 at 11:10 AM
$VRTX let’s get over 400 today. Please!!!🙏
0 · Reply
ChartHustla
ChartHustla Aug. 22 at 3:01 AM
$VRTX Vertex Pharmaceuticals dominates the cystic fibrosis market with a durable revenue stream pipeline beyond CF is the key to future growth
0 · Reply
pflory23
pflory23 Aug. 21 at 5:32 PM
$VRTX looking for any pullback to load more
0 · Reply
JoeB07
JoeB07 Aug. 21 at 3:28 PM
$INSM Why do the big holders continue to add shares at these prices!? Yes, Will Lewis is 3/3 on late stage drug trials. Yes, Brinsi is being compared to Humira, one of the biggest selling drugs in history. But the main reason they keep adding—Will Lewis is a business man. He’s indicated on CCs that he is not going to squander the revenue on a large numbers of frivolous research projects—think $VRTX. He’s going to start printing money for investors. And the big holders know this. And that’s why they continue to add at these crazy prices. Will Lewis isn’t only just focused on revenues, he’s going after profits too.
1 · Reply
Jmillie
Jmillie Aug. 21 at 3:41 AM
$VKTX think about how heavy shorts are right now. $VRTX potentially turned down $50 just last year. they could get acquired for $125 tomorrow. who knows. itll squeeze to $600 before they close the deal 😂😂 https://seekingalpha.com/news/4060945-viking-therapeutics-gains-amid-takeover-speculation
0 · Reply
JoeB07
JoeB07 Aug. 20 at 3:57 PM
$INSM $PLTR $VRTX $ALAB have fun! Get rich! Who wants to be an INSM millionaire with me!?
0 · Reply
Monkey_Banana_Genius
Monkey_Banana_Genius Aug. 20 at 2:24 PM
$VRTX trimmed some
2 · Reply
Monkey_Banana_Genius
Monkey_Banana_Genius Aug. 20 at 1:57 PM
$VRTX 💪
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 20 at 1:44 PM
$VRTX nice early pop
1 · Reply
falcon_trader11
falcon_trader11 Aug. 20 at 1:58 AM
$RNXT dipped after Q2 earnings due to a $2.9M loss, but don't miss the big wins! RenovoCath sales hit $422K, beating estimates by 28%. Now in 13 top cancer centers, up from 5, with repeat orders. Phase III trial got a green light, targeting a $1B+ market by early 2026. With $12.3M cash, a new sales pro, and TAMP cutting chemo side effects 65%, analysts see $4-$11.50 targets. PanTheR study starts by Sep end, plus ASTRO Sep 27-Oct 1 & AIMsymposium Nov 17. Missed $LLY at $705, $VRTX at $390, or $REGN at $572? $RNXT could be your next oncology star! $RNXT $LLY $VRTX $REGN
1 · Reply
nikant
nikant Aug. 18 at 9:31 PM
$NVO 🚀🚀💎. Wegovy was approved by FDA for the treatment of adults with non cirrhotic MASH (metabolic dysfunction-associated steatohepatitis) with moderate to advanced liver fibrosis. MASH is an unmet medical condition and Wegovy’s approval for MASH would greatly help patients. Estimates 1 in 20 people in the US are living with MASH and it is projected to increase by 2030. With Wegovy approval for MASH, Novo Nordisk will have a significant market share. Wegovy is also being tested for Alzheimer’s disease and it showed promising results, including improved memory function and reduction in brain plaque size in phase 2 clinical trials. Phase 3 trial is expected to be completed by end of September 2025. Novo Nordisk submitted a New Drug Application (NDA) to the FDA in May 2024 for oral Wegovy. The FDA is expected to make a decision on the NDA by the end of 2025 (Q4). The sky is the limit here and NVO is way under valued stock. $LLY $MRK $VRTX
0 · Reply
svertical1
svertical1 Aug. 17 at 12:01 PM
$VRTX Nothing has changed. Pain remains HHS/FDA priority. Vertex remains in great position!
1 · Reply
DayTrader111
DayTrader111 Aug. 17 at 12:26 AM
$VRTX CEO drops nearly $4M on the dip last week 👀 Rotation into Healthcare $XLV & Biotech $REGN
0 · Reply
RunnerSignals
RunnerSignals Aug. 16 at 6:28 PM
Top momentum stocks to watch next week: $BHC $FIVE $VRTX $FIVN $AFL. Trends, key levels, and volume spikes could shape price action https://stocksrunner.com/news/2025-08-16-weekly-momentum-stock-alerts-top-5-high-upside-picks-for-traders
0 · Reply
BosFreedom
BosFreedom Aug. 15 at 5:13 PM
$VRTX pump it!!!
0 · Reply
Etrading
Etrading Aug. 15 at 4:36 PM
0 · Reply
stockfrank1
stockfrank1 Aug. 15 at 3:26 PM
$VRTX $LLY out of the two, which one is a better buy?
2 · Reply
scientificway
scientificway Aug. 15 at 4:29 AM
$VRTX Loaded, XTNT, showing a strong support here and most likely going up from here.
0 · Reply
Intradaytrade100
Intradaytrade100 Aug. 14 at 1:27 PM
1 · Reply
Etrading
Etrading Aug. 14 at 1:25 PM
According to the US Government, the cost of health insurance has declined 19% over the last 5 years Are you kidding me ? 🐑 This stock market is fake and rigged All data are cooked to make sure market stay bull One way or other ; reality will come and market DUMP $SPY $QQQ $TLT $UNH $VRTX
3 · Reply
Monkey_Banana_Genius
Monkey_Banana_Genius Aug. 13 at 8:15 PM
$VRTX the🐒🍌🧠 bought when nobody wanted to touch it. Now up nicely on my position. Only ☝️
2 · Reply
BosFreedom
BosFreedom Aug. 13 at 8:11 PM
$VRTX let’s see $400 tomorrow!!!
0 · Reply